Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | PLG | P00747 | 2/20 | 0.42 |
| ▸ | KLK1 | P06870 | 2/20 | 0.42 |
| ▸ | KLK6 | Q92876 | 2/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29509787 | 0.82 | AMY1A (0.59) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL775197 | 0.82 | AMY1A (0.59) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL51100 | 0.81 | AMY1A (0.57) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL3069923 | 0.79 | TRPA1 (0.54) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL31191797 | 0.79 | TRPA1 (0.54) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL1006287 | 0.79 | TRPA1 (0.54) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL22859097 | 0.78 | TAAR1 (0.52) | ALOX15HSD17B10ALDH1A1TP53TDP1 | |
| SCHEMBL21917007 | 0.77 | TRPA1 (0.52) | TRPA1ALOX15HSD17B10ALDH1A1TP53 | |
| SCHEMBL3161137 | 0.77 | TAAR1 (0.47) | ALOX15TP53TDP1SLC6A2TAAR1 | |
| SCHEMBL14430064 | 0.77 | TRPA1 (0.52) | TRPA1ALOX15HSD17B10ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200261415-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | WICHITA STATE UNIVERSITY | 2020-08-20 | — | — | US | claimed |
| US-20190029998-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | WICHITA STATE UNIVERSITY | 2019-01-31 | — | — | US | claimed |
| EP-3408270-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | Wichita State University (US) | 2018-12-05 | — | — | EP | claimed |
| WO-2017132561-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | WICHITA STATE UNIVERSITY (US) | 2017-08-03 | — | — | WO | claimed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH, INC. | 2023-10-19 | — | — | US | disclosed |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | VANDERBILT UNIVERSITY (US) | 2023-07-11 | — | — | US | disclosed |
| EP-3408270-B1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | UNIV WICHITA STATE (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20200383938-A1 | COMPOUNDS AND METHODS FOR SCAVENGING DICARBONYL ELECTROPHILES | VANDERBILT UNIVERSITY | 2020-12-10 | — | — | US | disclosed |
| US-20200261415-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | WICHITA STATE UNIVERSITY | 2020-08-20 | — | — | US | disclosed |
| US-10668048-B2 | Compounds for inhibiting bacterial growth via phosphatidylglycerol binding | WICHITA STATE UNIVERSITY (US) | 2020-06-02 | — | — | US | disclosed |
| US-20190029998-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | WICHITA STATE UNIVERSITY | 2019-01-31 | — | — | US | disclosed |
| EP-3408270-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | Wichita State University (US) | 2018-12-05 | — | — | EP | disclosed |
| WO-2017132561-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | WICHITA STATE UNIVERSITY (US) | 2017-08-03 | — | — | WO | disclosed |
| US-20150265584-A1 | LEVUGLANDIN ADDUCTS HISTONE H4 IN A CYCLOOXYGENASE-2-DEPENDENT MANNER, ALTERING ITS INTERACTION WITH DNA | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2015-09-24 | — | — | US | disclosed |
| EP-0352960-A2 | Purine compounds, process for their preparation and pharmaceutical compositions | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1990-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200383938-A1 | COMPOUNDS AND METHODS FOR SCAVENGING DICARBONYL ELECTROPHILES | OGG1, LGMN, GLO1 | TRPA1 1725/4885ALOX15 462/4885HSD17B10 646/4885 |
| US-10668048-B2 | Compounds for inhibiting bacterial growth via phosphatidylglycerol binding | PEBP1, PHOSPHO1, BPGM | TRPA1 4577/4885ALOX15 669/4885HSD17B10 1919/4885 |
| US-20200261415-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | PEBP1, PHOSPHO1, BPGM | TRPA1 4577/4885ALOX15 669/4885HSD17B10 1919/4885 |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | FABP2, SI, MLN | TRPA1 3226/4885ALOX15 621/4885HSD17B10 2890/4885 |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | TRPA1 4358/4885ALOX15 510/4885HSD17B10 147/4885 |
| US-20190029998-A1 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | PEBP1, PHOSPHO1, BPGM | TRPA1 4577/4885ALOX15 669/4885HSD17B10 1919/4885 |
| US-20150265584-A1 | LEVUGLANDIN ADDUCTS HISTONE H4 IN A CYCLOOXYGENASE-2-DEPENDENT MANNER, ALTERING ITS INTERACTION WITH DNA | H1-2, H1-4, H1-3 | TRPA1 1983/4885ALOX15 705/4885HSD17B10 251/4885 |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | OGG1, LGMN, GLO1 | TRPA1 1725/4885ALOX15 462/4885HSD17B10 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.